Oscar Health (NYSE:OSCR) Reaches New 12-Month Low – Here’s What Happened

Oscar Health, Inc. (NYSE:OSCR) reached a new 52-week low during mid-day trading on Friday . The company traded as low as $11.16 and last traded at $11.1410, with a volume of 3626111 shares trading hands. The stock had previously closed at $11.84.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on OSCR shares. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a research note on Thursday, February 12th. Barclays set a $18.00 target price on Oscar Health and gave the company an “equal weight” rating in a research report on Monday, January 5th. Stephens started coverage on Oscar Health in a report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price target on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Thursday, January 22nd. Finally, Wall Street Zen raised Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday, February 14th. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Oscar Health has a consensus rating of “Hold” and a consensus target price of $16.88.

Oscar Health Stock Performance

The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.96 and a current ratio of 0.96. The stock has a market cap of $3.32 billion, a P/E ratio of -6.41 and a beta of 1.91. The firm’s 50 day moving average is $13.64 and its 200 day moving average is $16.09.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The firm had revenue of $2.81 billion during the quarter, compared to analyst estimates of $3.12 billion. During the same quarter last year, the business earned ($0.62) earnings per share. Oscar Health’s revenue was up 17.3% on a year-over-year basis. Analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 23,038 shares of the company’s stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $17.65, for a total transaction of $406,620.70. Following the transaction, the insider directly owned 350,180 shares of the company’s stock, valued at $6,180,677. This represents a 6.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 24.39% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in OSCR. BIT Capital GmbH raised its holdings in shares of Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after buying an additional 5,227,152 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock valued at $100,298,000 after buying an additional 2,495,691 shares during the last quarter. Farallon Capital Management LLC grew its holdings in shares of Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock valued at $68,886,000 after buying an additional 2,163,000 shares during the last quarter. Morgan Stanley increased its position in shares of Oscar Health by 42.8% in the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock valued at $97,918,000 after acquiring an additional 2,043,758 shares during the period. Finally, Thrive Capital Management LLC increased its position in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.